公司资料
QAthersys, Inc. 股价、新闻与催化剂
- 股票代码:
- ATHX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for ATHX.
公司概览
业务概览
Athersys was a regenerative medicine company focused on cell therapy and acute inflammatory conditions before becoming a historical biotech name. Its story revolved around stem-cell science and the challenge of moving it into a practical treatment.
所在地与行业分类
Athersys was headquartered in the United States and listed on NASDAQ. It sat in regenerative medicine and biotechnology.
商业模式特征
The company depended on clinical proof, manufacturing feasibility, and a constant need for financing. Investors historically followed readouts, strategic shifts, and whether the platform could survive long enough to scale.
生物医药行业定位
Athersys occupies the historical regenerative-medicine bucket. Like many cell-therapy developers, it was highly sensitive to capital and clinical execution.
未来催化剂
- Athersys is largely a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. The market is mainly focused on what remains after the restructuring.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。